Close

Plus Therapeutics (PSTV) Announces DSMB Approval to Proceed into Eighth Cohort in ReSPECT Glioblastoma Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. CMG
4. MSFT
5. LRCX
6. IBM
7. SPY
8. INTC
9. SNAP
10. BA


Go back to Plus Therapeutics (PSTV) Announces DSMB Approval to Proceed into Eighth Cohort in ReSPECT Glioblastoma Trial
(NASDAQ: PSTV) Delayed: 1.67 +0.07 (4.38%)
Previous Close $1.60    52 Week High $ 
Open $1.62    52 Week Low $ 
Day High $1.67    P/E N/A 
Day Low $1.52    EPS $ 
Volume 5,262